{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:38:32Z","timestamp":1793997512304,"version":"4.8.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201506270162"],"award-info":[{"award-number":["201506270162"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.drudis.2021.05.011","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T17:03:37Z","timestamp":1621616617000},"page":"2699-2706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Nicotinamide N-methyl transferase (NNMT): An emerging therapeutic target"],"prefix":"10.1016","volume":"26","author":[{"given":"Yongzhi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-3006","authenticated-orcid":false,"given":"Nathaniel I.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs J.","family":"van Haren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.drudis.2021.05.011_b0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0959-440X(02)00391-3","article-title":"SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold","volume":"12","author":"Martin","year":"2002","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"10.1016\/j.drudis.2021.05.011_b0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9258(18)56110-X","article-title":"Methylation of nicotinamide with soluble enzyme system from rat liver","volume":"189","author":"Cantoni","year":"1951","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.drudis.2021.05.011_b0015","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1021\/ja01131a519","article-title":"The nature of the active methyl donor formed enzymatically from L-methionine and adenosinetriphosphate","volume":"74","author":"Cantoni","year":"1952","journal-title":"J Am Chem Soc"},{"issue":"20","key":"10.1016\/j.drudis.2021.05.011_b0020","doi-asserted-by":"crossref","first-page":"14835","DOI":"10.1016\/S0021-9258(17)36700-5","article-title":"Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization","volume":"269","author":"Aksoy","year":"1994","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.drudis.2021.05.011_b0025","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0006-2952(97)00325-0","article-title":"Mouse liver nicotinamide N-methyltransferase: CDNA cloning expression, and nucleotide sequence polymorphisms","volume":"54","author":"Yan","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"36","key":"10.1016\/j.drudis.2021.05.011_b0030","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1021\/bi2007614","article-title":"Structural basis of substrate recognition in human nicotinamide N-methyltransferase","volume":"50","author":"Peng","year":"2011","journal-title":"Biochemistry"},{"issue":"21","key":"10.1016\/j.drudis.2021.05.011_b0035","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1021\/acs.jmedchem.9b01238","article-title":"High-affinity alkynyl bisubstrate inhibitors of nicotinamide N-methyltransferase (NNMT)","volume":"62","author":"Policarpo","year":"2019","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.drudis.2021.05.011_b0040","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0003-9861(88)90487-0","article-title":"Substrate specificity of nicotinamide methyltransferase isolated from porcine liver","volume":"260","author":"Alston","year":"1988","journal-title":"Arch Biochem Biophys"},{"issue":"37","key":"10.1016\/j.drudis.2021.05.011_b0045","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1021\/acs.biochem.6b00733","article-title":"A rapid and efficient assay for the characterization of substrates and inhibitors of nicotinamide N-methyltransferase","volume":"55","author":"van Haren","year":"2016","journal-title":"Biochemistry"},{"issue":"38","key":"10.1016\/j.drudis.2021.05.011_b0050","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1021\/acs.biochem.8b00775","article-title":"Kinetic mechanism of nicotinamide N-methyltransferase","volume":"57","author":"Loring","year":"2018","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.drudis.2021.05.011_b0055","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/acs.jmedchem.7b01422","article-title":"Discovery of bisubstrate inhibitors of nicotinamide N-methyltransferase (NNMT)","volume":"61","author":"Babault","year":"2018","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.drudis.2021.05.011_b0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2017.02.004","article-title":"methyltransferase: more than a vitamin B3 clearance enzyme","volume":"28","author":"Pissios","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"40","key":"10.1016\/j.drudis.2021.05.011_b0065","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1021\/acs.biochem.8b00561","article-title":"Nicotinamide N-methyltransferase interacts with enzymes of the methionine cycle and regulates methyl donor metabolism","volume":"57","author":"Hong","year":"2018","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.drudis.2021.05.011_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26882-8","article-title":"NNMT activation can contribute to the development of fatty liver disease by modulating the NAD+ metabolism","volume":"8","author":"Komatsu","year":"2018","journal-title":"Sci Rep"},{"issue":"32","key":"10.1016\/j.drudis.2021.05.011_b0075","doi-asserted-by":"crossref","first-page":"15957","DOI":"10.1073\/pnas.1902346116","article-title":"Identification of evolutionary and kinetic drivers of NAD-dependent signaling","volume":"116","author":"Bockwoldt","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.drudis.2021.05.011_b0080","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.3882","article-title":"Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization","volume":"21","author":"Hong","year":"2015","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.drudis.2021.05.011_b0085","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nchembio.1352","article-title":"Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide","volume":"9","author":"Schmeisser","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"9","key":"10.1016\/j.drudis.2021.05.011_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007561","article-title":"Nicotinamide-N-methyltransferase controls behavior, neurodegeneration and lifespan by regulating neuronal autophagy","volume":"14","author":"Schmeisser","year":"2018","journal-title":"PLOS Genet"},{"key":"10.1016\/j.drudis.2021.05.011_b0095","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691739","article-title":"Nicotinamide N-methyltransferase in health and cancer","volume":"10","author":"Ramsden","year":"2017","journal-title":"Int J Tryptophan Res"},{"issue":"05","key":"10.1016\/j.drudis.2021.05.011_b0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4149\/neo_2018_171024N680","article-title":"Nicotinamide N-methyltransferase as a potential marker for cancer","volume":"65","author":"Lu","year":"2018","journal-title":"Neoplasma"},{"issue":"5","key":"10.1016\/j.drudis.2021.05.011_b0105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"7758","key":"10.1016\/j.drudis.2021.05.011_b0110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","article-title":"Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts","volume":"569","author":"Eckert","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.drudis.2021.05.011_b0115","doi-asserted-by":"crossref","first-page":"eabe1174","DOI":"10.1126\/sciadv.abe1174","article-title":"1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer","volume":"7","author":"Kilgour","year":"2021","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.drudis.2021.05.011_b0120","article-title":"Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.drudis.2021.05.011_b0125","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1158\/1078-0432.CCR-16-1323","article-title":"NNMT silencing activates tumor suppressor PP2A, inactivates oncogenic STKs, and inhibits tumor forming ability","volume":"23","author":"Palanichamy","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.drudis.2021.05.011_b0130","article-title":"RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells","volume":"8","author":"Giannatempo","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.drudis.2021.05.011_b0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1515\/hsz-2014-0231","article-title":"Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity","volume":"396","author":"Sartini","year":"2015","journal-title":"Biol Chem"},{"issue":"8","key":"10.1016\/j.drudis.2021.05.011_b0140","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1210\/jc.2015-1732","article-title":"Serum N1-methylnicotinamide is associated with obesity and diabetes in Chinese","volume":"100","author":"Liu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"7495","key":"10.1016\/j.drudis.2021.05.011_b0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nature13198","article-title":"Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity","volume":"508","author":"Kraus","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.drudis.2021.05.011_b0150","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1038\/s41598-018-22081-7","article-title":"A small molecule inhibitor of Nicotinamide N\u2013methyltransferase for the treatment of metabolic disorders","volume":"8","author":"Kannt","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.drudis.2021.05.011_b0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2337\/db18-0780","article-title":"Genetic nicotinamide N-methyltransferase (Nnmt) deficiency in male mice improves insulin sensitivity in diet-induced obesity but does not affect glucose tolerance","volume":"68","author":"Brachs","year":"2019","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.drudis.2021.05.011_b0160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab"},{"issue":"1\u20132","key":"10.1016\/j.drudis.2021.05.011_b0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(03)00218-0","article-title":"High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson\u2019s disease","volume":"342","author":"Parsons","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.drudis.2021.05.011_b0170","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s12035-020-02259-9","article-title":"High expression of nicotinamide N-methyltransferase in patients with sporadic Alzheimer\u2019s disease","volume":"58","author":"Kocinaj","year":"2021","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.drudis.2021.05.011_b0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-016-0423-7","article-title":"Activation of the nicotinamide N-methyltransferase (NNMT)-1\u2013methylnicotinamide (MNA) pathway in pulmonary hypertension","volume":"17","author":"Fedorowicz","year":"2016","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.drudis.2021.05.011_b0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2217\/epi.15.113","article-title":"Methyltransferase-Glo: a universal, bioluminescent and homogenous assay for monitoring all classes of methyltransferases","volume":"8","author":"Hsiao","year":"2016","journal-title":"Epigenomics"},{"issue":"12","key":"10.1016\/j.drudis.2021.05.011_b0185","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1248\/cpb.37.3330","article-title":"Fluorometric assay of nicotinamide methyltransferase with a new substrate, 4-methylnicotinamide","volume":"37","author":"Sano","year":"1989","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"10.1016\/j.drudis.2021.05.011_b0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1248\/cpb.40.153","article-title":"Fluorometric Assay of rat tissue N-methyltransferases with nicotinamide and four isomeric methylnicotinamides","volume":"40","author":"Sano","year":"1992","journal-title":"Chem Pharm Bull"},{"issue":"6","key":"10.1016\/j.drudis.2021.05.011_b0195","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/acs.biochem.6b01215","article-title":"Noncoupled fluorescent assay for direct real-time monitoring of nicotinamide N-methyltransferase activity","volume":"56","author":"Neelakantan","year":"2017","journal-title":"Biochemistry"},{"issue":"31","key":"10.1016\/j.drudis.2021.05.011_b0200","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1039\/C7OB01357D","article-title":"Inhibitors of nicotinamide N-methyltransferase designed to mimic the methylation reaction transition state","volume":"15","author":"van Haren","year":"2017","journal-title":"Org Biomol Chem"},{"issue":"3","key":"10.1016\/j.drudis.2021.05.011_b0205","first-page":"255","article-title":"Evaluation of sinefungin for the treatment of Trypanosoma (Nannomonas) congolense infections in goats","volume":"37","author":"Zweygarth","year":"1986","journal-title":"Trop Med Parasitol"},{"issue":"12","key":"10.1016\/j.drudis.2021.05.011_b0210","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1021\/acs.jmedchem.7b00389","article-title":"Structure-activity relationship for small molecule inhibitors of nicotinamide N-methyltransferase","volume":"60","author":"Neelakantan","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2021.05.011_b0215","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bcp.2019.02.008","article-title":"Small molecule nicotinamide N-methyltransferase inhibitor activates senescent muscle stem cells and improves regenerative capacity of aged skeletal muscle","volume":"163","author":"Neelakantan","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2021.05.011_b0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcp.2017.11.007","article-title":"Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice","volume":"147","author":"Neelakantan","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.drudis.2021.05.011_b0225","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bmcl.2018.01.058","article-title":"Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase","volume":"28","author":"Ruf","year":"2018","journal-title":"Bioorganic Med Chem Lett"},{"issue":"4","key":"10.1016\/j.drudis.2021.05.011_b0230","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/molecules26040991","article-title":"Novel inhibitors of nicotinamide-N-methyltransferase for the treatment of metabolic disorders","volume":"26","author":"Kannt","year":"2021","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.drudis.2021.05.011_b0235","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1021\/acs.jmedchem.9b00413","article-title":"Bisubstrate inhibitors of nicotinamide N-methyltransferase (NNMT) with enhanced activity","volume":"62","author":"Gao","year":"2019","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.drudis.2021.05.011_b0240","doi-asserted-by":"crossref","first-page":"10783","DOI":"10.1021\/acs.jmedchem.9b01255","article-title":"Novel propargyl-linked bisubstrate analogues as tight-binding inhibitors for nicotinamide N-methyltransferase","volume":"62","author":"Chen","year":"2019","journal-title":"J Med Chem"},{"issue":"40","key":"10.1016\/j.drudis.2021.05.011_b0245","doi-asserted-by":"crossref","first-page":"13335","DOI":"10.1021\/jacs.6b07830","article-title":"Chemical proteomic profiling of human methyltransferases","volume":"138","author":"Horning","year":"2016","journal-title":"J Am Chem Soc"},{"issue":"16","key":"10.1016\/j.drudis.2021.05.011_b0250","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.bmcl.2018.04.017","article-title":"Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ","volume":"28","author":"Lee","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/j.drudis.2021.05.011_b0255","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acschembio.9b00211","article-title":"Development of a suicide inhibition-based protein labeling strategy for nicotinamide N-methyltransferase","volume":"14","author":"Sen","year":"2019","journal-title":"ACS Chem Biol"},{"issue":"22","key":"10.1016\/j.drudis.2021.05.011_b0260","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1021\/jacs.9b02822","article-title":"Rapid covalent-probe discovery by electrophile-fragment screening","volume":"141","author":"Resnick","year":"2019","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.drudis.2021.05.011_b0265","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bmc.2004.10.054","article-title":"Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa","volume":"13","author":"Zhan","year":"2005","journal-title":"Bioorganic Med Chem"},{"issue":"10","key":"10.1016\/j.drudis.2021.05.011_b0270","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/S0968-0896(02)00163-3","article-title":"Neurotrophic and antileukemic daphnane diterpenoids from Synaptolepis kirkii","volume":"10","author":"He","year":"2002","journal-title":"Bioorganic Med Chem"},{"issue":"11","key":"10.1016\/j.drudis.2021.05.011_b0275","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.bmc.2006.01.055","article-title":"Preparation of yuanhuacine and relative daphne diterpene esters from Daphne genkwa and structure\u2013activity relationship of potent inhibitory activity against DNA topoisomerase I","volume":"14","author":"Zhang","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/j.drudis.2021.05.011_b0280","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1021\/np2003512","article-title":"Growth inhibition of human lung cancer cells via down-regulation of epidermal growth factor receptor signaling by Yuanhuadine, a daphnane diterpene from Daphne genkwa","volume":"74","author":"Hong","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.drudis.2021.05.011_b0285","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.omtn.2018.03.011","article-title":"Targeting nicotinamide N-methyltransferase and miR-449a in EGFR-TKI-resistant non-small-cell lung cancer cells","volume":"11","author":"Bach","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.drudis.2021.05.011_b0290","doi-asserted-by":"crossref","unstructured":"van Haren MJ, Zhang Y, Buijs N, Thijssen V, Sartini D, Emanuelli M, et al. Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT). chemRxiv. Published online September 18, 2020. http:\/\/dx.doi.org\/10.26434\/chemrxiv.12973130.v1.","DOI":"10.26434\/chemrxiv.12973130.v1"},{"key":"10.1016\/j.drudis.2021.05.011_b0295","unstructured":"Ruenoplaza G, inventor; Eli Lilly and Company. Pyrimidine-5-carboxamide compound. WO 2021\/025975 A1."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621002427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621002427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:55:28Z","timestamp":1761224128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644621002427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1359644621002427"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2021.05.011","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide N-methyl transferase (NNMT): An emerging therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2021.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}